Speech-Language Pathologists in Saint Marys, PA Accepting Medicare

10 Speech-Language Pathologists found. Showing 1 - 10

Gina Pistner, MS. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elm Rd, Saint Marys, PA 15857 Phone: 814-335-9503

Rebecca Lynn Kronenwetter, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 763 Johnsonburg Rd, Rehab Building, Saint Marys, PA 15857 Phone: 814-788-8687

Chelsea Samick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1161 Brusselles St, Saint Marys, PA 15857 Phone: 814-594-3755

Tricia L Stauffer, M.S. C.C.C. SLP/L Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 757 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-788-8687    Fax: 814-788-8091

Mrs. Jennifer Wingard, M.S. SLP/CCC/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1293 S Michael Rd, Saint Marys, PA 15857 Phone: 814-389-1471

Lori Elizabeth Mahoney, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 763 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-788-8136    Fax: 814-788-8091

Jessica Lynn Cunningham, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 763 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-788-8311

Delaney K Hildebrand, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 222 Muenster Rd, Saint Marys, PA 15857 Phone: 814-335-6727

Jamie Yetzer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 785 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-834-2618

Morgan Elizabeth Secco, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 785 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-834-2618

News Archive

NYU wins roughly $4 million federal grant to protect transit workers from COVID-19

NYU School of Global Public Health researchers have been awarded a five-year, roughly $4 million grant from the National Institutes of Health to study efforts to protect New York City transit workers from COVID-19 and how these infection prevention and control programs impact the health and well-being of frontline workers.

Clinical study demonstrates potential of regenerative therapy for hypoplastic left heart syndrome

A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery.

FAU professor highlights the need for extensive randomized trials to distinguish drug benefits

In a commentary published in the December 2, 2009 issue of the Journal of the American Medical Association, Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science at Florida Atlantic University, said, "To detect the most likely small to moderate benefits or harm of drugs requires randomized trials of sufficient size and duration. Overreliance on small trials, meta-analyses or subgroup analyses can lead to misleading conclusions."

Medicare reimbursement cuts lead to decline in unnecessary or inappropriate care

When Medicare policy changes led to reductions in reimbursement for hormonal treatment of prostate cancer, there was a sharp decline in its use among patients not likely to benefit from the treatment. But among patients for whom the therapy is clearly beneficial, doctors continued to prescribe it at the same rate, according to a new study.

Read more Medical News

› Verified 8 days ago